Cell Therapy Department within Genentech Research and Early Discovery (gRED), specializes in developing innovative treatments where the therapeutic agent is a living cell rather than a traditional molecule, antibody, or DNA strand. The team works with a wide variety of cell types derived from different tissues and organs, with a primary focus on utilizing stem cells to generate these therapeutic cells.
A key aspect of their work is cell engineering.
They enhance the functionality of these cells by incorporating genetic modifications, typically through DNA alterations. This approach equips the cells with advanced capabilities, optimizing their effectiveness in therapeutic applications.
